(Q45771069)

15 December 2017

title

Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation (English)

1 reference

15 December 2017

1 reference

0 references

Montone KT

1

1 reference

15 December 2017

Litzky LA

2

1 reference

15 December 2017

Wurster A

3

1 reference

15 December 2017

Kaiser L

4

1 reference

15 December 2017

Bavaria J

5

1 reference

15 December 2017

Kotloff R

6

1 reference

15 December 2017

Palevsky H

7

1 reference

15 December 2017

Pietra GG

8

1 reference

15 December 2017

Tomaszewski JE

9

1 reference

15 December 2017

language of work or name

1 reference

1 May 1996

1 reference

15 December 2017

published in

Surgery

1 reference

15 December 2017

volume

119

1 reference

15 December 2017

page(s)

544-551

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Lymphadenopathy in renal transplant patients treated with immunosuppressive antibodies (OKT3 and anti-thymocyte globulin). A report of nine cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Epstein-Barr Virus Infection Acquired from a Cadaveric Renal Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

A poorly differentiated lymphoma of donor origin in a renal allograft recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980265-0

7 January 2021

10.1016/S0039-6060(96)80265-0

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

8619211

1 reference

15 December 2017